Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia

Journal of Biological Chemistry

Volumn 288, Issue 32, 2013, Pages 22915-22929

  Spallotta, Francesco ^a,h   Tardivo, Silvia ^b,i   Nanni, Simona ^c,g   Rosati, Jessica D ^b   Straino, Stefania ^b,d   Mai, Antonello ^e   Vecellio, Matteo ⁱ   Valente, Sergio ^e   Capogrossi, Maurizio C ^b   Farsetti, Antonella ^f,g   Martone, Julie ^e   Bozzoni, Irene ^e   Pontecorvi, Alfredo ^c   Gaetano, Carlo ^h   Colussi, Claudia ^c,g  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Explora Biotech   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f CNR   (Italy)

^g REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^h GOETHE UNIVERSITY   (Germany)

ⁱ Ist Casa Sollievo Sofferenza Mendel   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; CLASS I; DIFFERENT STAGES; HIND LIMBS; HISTONE DEACETYLASE INHIBITOR; MUSCLE RECONSTRUCTION; MUSCLE REGENERATION;

BIOCHEMISTRY; BIOLOGY;

MUSCLE;

3 [4 [3 (3 FLUOROPHENYL) 3 OXO 1 PROPENYL] 1 METHYL 1H PYRROL 2 YL]ACRYLOHYDROXAMIC ACID; DYSTROPHIN; ENTINOSTAT; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 2A; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE 2A; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; EPIGENETICS; HINDLIMB; LIMB ISCHEMIA; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE REGENERATION; MYOFIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DIFFERENTIATION;

EPIGENETICS; HISTONE DEACETYLASE INHIBITORS; ISCHEMIA; MUSCLE REGENERATION; NITRIC OXIDE; PROTEIN PHOSPHATASE 2A;

ANIMALS; BENZAMIDES; DYSTROPHIN; HINDLIMB; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; ISCHEMIA; MALE; MICE; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE I; PROTEIN PHOSPHATASE 2; PYRIDINES; PYRROLES; REGENERATION; TIME FACTORS;

EID: 84881396773     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.484337     Document Type: Article

References (41)

1. Sneider, E. B., Nowicki, P. T., and Messina, L. M. (2009) Regenerative medicine in the treatment of peripheral arterial disease. J. Cell. Biochem. 108, 753-761
2. Colussi, C., Illi, B., Rosati, J., Spallotta, F., Farsetti, A., Grasselli, A., Mai, A., Capogrossi, M. C., and Gaetano, C. (2010) Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment. Pharmacol. Res. 62, 3-10
3. McKinsey, T. A. (2012) Therapeutic potential for HDAC inhibitors in the heart. Annu. Rev. Pharmacol. Toxicol. 52, 303-319
4. Narlikar, G. J., Fan, H. Y., and Kingston, R. E. (2002) Cooperation between complexes that regulate chromatin structure and transcription. Cell 108, 475-487
5. Hildmann, C., Riester, D., and Schwienhorst, A. (2007) Histone deacetylases: an important class of cellular regulators with a variety of functions. Appl. Microbiol. Biotechnol. 75, 487-497
6. Ficner, R. (2009) Novel structural insights into class I and II histone deacetylases. Curr. Top. Med. Chem. 9, 235-240
7. Margariti, A., Zampetaki, A., Xiao, Q., Zhou, B., Karamariti, E., Martin, D., Yin, X., Mayr, M., Li, H., Zhang, Z., De Falco, E., Hu, Y., Cockerill, G., Xu, Q., and Zeng, L. (2010) Histone deacetylase 7 controls endothelial cell growth through modulation of-catenin. Circ. Res. 106, 1202-1211
8. Grozinger, C. M., and Schreiber, S. L. (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. U.S.A. 97, 7835-7840
9. Wang, A. H., Kruhlak, M. J., Wu, J., Bertos, N. R., Vezmar, M., Posner, B. I., Bazett-Jones, D. P., and Yang, X. J. (2000) Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 20, 6904-6912
10. McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000) Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulindependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. U.S.A. 97, 14400-14405
11. McKinsey, T. A., Zhang, C. L., Lu, J., and Olson, E. N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111
12. Illi, B., Dello Russo, C., Colussi, C., Rosati, J., Pallaoro, M., Spallotta, F., Rotili, D., Valente, S., Ragone, G., Martelli, F., Biglioli, P., Steinkuhler, C., Gallinari, P., Mai, A., Capogrossi, M. C., and Gaetano, C. (2008) Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ. Res. 102, 51-58
13. Colussi, C., Gurtner, A., Rosati, J., Illi, B., Ragone, G., Piaggio, G., Moggio, M., Lamperti, C., D'Angelo, G., Clementi, E., Minetti, G., Mozzetta, C., Antonini, A., Capogrossi, M. C., Puri, P. L., and Gaetano, C. (2009) Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. FASEB J. 23, 2131-2141
14. McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2001) Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11, 497-504
15. Lu, J., McKinsey, T. A., Nicol, R. L., and Olson, E. N. (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. U.S.A. 97, 4070-4075
16. Nebbioso, A., Manzo, F., Miceli, M., Conte, M., Manente, L., Baldi, A., De Luca, A., Rotili, D., Valente, S., Mai, A., Usiello, A., Gronemeyer, H., and Altucci, L. (2009) Selective class IIHDACinhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep. 10, 776-782
17. Minetti, G. C., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Di Padova, M., Illi, B., Gallinari, P., Steinkühler, C., Capogrossi, M. C., Sartorelli, V., Bottinelli, R., Gaetano, C., and Puri, P. L. (2006) Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12, 1147-1150
18. Zaccagnini, G., Martelli, F., Fasanaro, P., Magenta, A., Gaetano, C., Di Carlo, A., Biglioli, P., Giorgio, M., Martin-Padura, I., Pelicci, P. G., and Capogrossi, M. C. (2004) p66ShcA modulates tissue response to hindlimb ischemia. Circulation 109, 2917-2923
19. Colussi, C., Rosati, J., Straino, S., Spallotta, F., Berni, R., Stilli, D., Rossi, S., Musso, E., Macchi, E., Mai, A., Sbardella, G., Castellano, S., Chimenti, C., Frustaci, A., Nebbioso, A., Altucci, L., Capogrossi, M. C., and Gaetano, C. (2011) N-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc. Natl. Acad. Sci. U.S.A. 108, 2795-2800
20. Henke, N., Schmidt-Ullrich, R., Dechend, R., Park, J. K., Qadri, F., Wellner, M., Obst, M., Gross, V., Dietz, R., Luft, F. C., Scheidereit, C., and Muller, D. N. (2007) Vascular endothelial cell-specific NF-κB suppression attenuates hypertension-induced renal damage. Circ. Res. 101, 268-276
21. Nanni, S., Benvenuti, V., Grasselli, A., Priolo, C., Aiello, A., Mattiussi, S., Colussi, C., Lirangi, V., Illi, B., D'Eletto, M., Cianciulli, A. M., Gallucci, M., De Carli, P., Sentinelli, S., Mottolese, M., Carlini, P., Strigari, L., Finn, S., Mueller, E., Arcangeli, G., Gaetano, C., Capogrossi, M. C., Donnorso, R. P., Bacchetti, S., Sacchi, A., Pontecorvi, A., Loda, M., and Farsetti, A. (2009) Endothelial NOS, estrogen receptor, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J. Clin. Invest. 119, 1093-1108
22. Nanni, S., Priolo, C., Grasselli, A., D'Eletto, M., Merola, R., Moretti, F., Gallucci, M., De Carli, P., Sentinelli, S., Cianciulli, A. M., Mottolese, M., Carlini, P., Arcelli, D., Helmer-Citterich, M., Gaetano, C., Loda, M., Pontecorvi, A., Bacchetti, S., Sacchi, A., and Farsetti, A. (2006) Epithelialrestricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol. Cancer Res. 4, 79-92
23. Gurtner, A., Fuschi, P., Magi, F., Colussi, C., Gaetano, C., Dobbelstein, M., Sacchi, A., and Piaggio, G. (2008) NF-Y-dependent epigenetic modifications discriminate between proliferating and postmitotic tissue. PloS One 3, e2047
24. Straino, S., Germani, A., Di Carlo, A., Porcelli, D., De Mori, R., Mangoni, A., Napolitano, M., Martelli, F., Biglioli, P., and Capogrossi, M. C. (2004) Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110, 3341-3348
25. Mai, A., Massa, S., Pezzi, R., Simeoni, S., Rotili, D., Nebbioso, A., Scognamiglio, A., Altucci, L., Loidl, P., and Brosch, G. (2005) Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J. Med. Chem. 48, 3344-3353
26. Colussi, C., Mozzetta, C., Gurtner, A., Illi, B., Rosati, J., Straino, S., Ragone, G., Pescatori, M., Zaccagnini, G., Antonini, A., Minetti, G., Martelli, F., Piaggio, G., Gallinari, P., Steinkuhler, C., Clementi, E., Dell'Aversana, C., Altucci, L., Mai, A., Capogrossi, M. C., Puri, P. L., and Gaetano, C. (2008) HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc. Natl. Acad. Sci. U.S.A. 105, 19183-19187
27. Nott, A., Watson, P. M., Robinson, J. D., Crepaldi, L., and Riccio, A. (2008) S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455, 411-415
28. Goljanek-Whysall, K., Pais, H., Rathjen, T., Sweetman, D., Dalmay, T., and Münsterberg, A. (2012) Regulation of multiple target genes by miR-1/ miR-206 is pivotal for C2C12 myoblast differentiation. J. Cell Sci. 125, 3590-3600
29. Chen, J. F., Tao, Y., Li, J., Deng, Z., Yan, Z., Xiao, X., and Wang, D. Z. (2010) microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 190, 867-879
30. Cacchiarelli, D., Martone, J., Girardi, E., Cesana, M., Incitti, T., Morlando, M., Nicoletti, C., Santini, T., Sthandier, O., Barberi, L., Auricchio, A., Musarò, A., and Bozzoni, I. (2010) MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 12, 341-351
31. Liu, N., Williams, A. H., Maxeiner, J. M., Bezprozvannaya, S., Shelton, J. M., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054-2065
32. Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P., Meola, G., Capogrossi, M. C., Gaetano, C., and Martelli, F. (2009)Commonmicro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 23, 3335-3346
33. Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., Huang, P. L., and Isner, J. M. (1998) Nitric-oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101, 2567-2578
34. Spallotta, F., Cencioni, C., Straino, S., Nanni, S., Rosati, J., Artuso, S., Manni, I., Colussi, C., Piaggio, G., Martelli, F., Valente, S., Mai, A., Capogrossi, M. C., Farsetti, A., and Gaetano, C. (2013)Anitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. J. Biol. Chem. 288, 11004-11012
35. Troidl, K., and Schaper, W. (2012) Arteriogenesis versus angiogenesis in peripheral artery disease. Diabetes Metab. Res. Rev. 28, 27-29
36. Al Haj Zen, A., and Madeddu, P. (2009) Notch signalling in ischaemiainduced angiogenesis. Biochem. Soc. Trans. 37, 1221-1227
37. Zhou, B., Margariti, A., Zeng, L., and Xu, Q. (2011) Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc. Res. 90, 413-420
38. Yan, J., Tie, G., Hoffman, A., Yang, Y., Nowicki, P. T., and Messina, L. M. (2010) Oral tetrahydrobiopterin improves the beneficial effect of adenoviral-mediated eNOS gene transfer after induction of hindlimb ischemia. Mol. Ther. 18, 1482-1489
39. Xu, Q., Lin, X., Andrews, L., Patel, D., Lampe, P. D., and Veenstra, R. D. (2013) Histone deacetylase inhibition reduces cardiac connexin43 expression and gap junction communication. Front. Pharmacol. 4, 44
40. Shah, M. H., Binkley, P., Chan, K., Xiao, J., Arbogast, D., Collamore, M., Farra, Y., Young, D., and Grever, M. (2006) Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clin. Cancer Res. 12, 3997-4003
41. Karagiannis, T. C., Lin, A. J., Ververis, K., Chang, L., Tang, M. M., Okabe, J., and El-Osta, A. (2010) TrichostatinAaccentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging 2, 659-668